Thalidomide as an anti-angiogenic agent in relapsed gliomas

Journal of Neuro-Oncology

Volumn 51, Issue 1, 2001, Pages 41-45

  Short, S C ^a   Traish, D ^a   Dowe, A ^a   Hines, F ^a   Gore, M ^a   Brada, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Anti angiogenesis; Glioma; Thalidomide

Indexed keywords

ANGIOGENESIS INHIBITOR; CARMUSTINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; THALIDOMIDE; VINCRISTINE;

ADULT; ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL TRANSFORMATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; GLIOMA; HUMAN; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRESCRIPTION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADULT; ANGIOGENESIS INHIBITORS; BRAIN NEOPLASMS; DISEASE PROGRESSION; GLIOMA; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; THALIDOMIDE; TREATMENT OUTCOME;

EID: 0035051092     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006414804835     Document Type: Article

References (23)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Induction of angiogenesis during the transition from hyperplasia to neoplasia
3. The role of angiogenesis in tumor growth
4. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
5. New strategies in anti-vascular cancer therapy
6. Angiogenesis and angiogenesis inhibitors in cancer
7. KDR activation in astrocytic neoplasms
8. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours
9. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas
10. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: A review
11. Thalidomide is an inhibitor of angiogenesis
12. The effect of thalidomide on experimental tumours and metastases
13. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
14. Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
15. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide
16. Use of thalidomide in leprosy
17. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis
18. Response criteria for phase II studies of supratentorial gliomas
19. New treatment strategies for malignant gliomas
20. Tumor angiogenesis-A new therapeutic target in gliomas
21. Antitumor activity of thalidomide in refractory multiple myeloma
22. Tumor-induced angiogenesis: Lack of inhibition by irradiation
23. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas